罗哌卡因:最新的麻醉剂诞生20周年

Revista Dor Pub Date : 2017-12-01 DOI:10.5935/1806-0013.20170117

J. Nociti

{"title":"罗哌卡因:最新的麻醉剂诞生20周年","authors":"J. Nociti","doi":"10.5935/1806-0013.20170117","DOIUrl":null,"url":null,"abstract":"On February 22, 1997, the first European Symposium on Ropivacaine was held in Stockholm, Sweden, with the participation of 554 anesthesiologists from 22 countries, including 11 from Brazil. In the same year, Astra Laboratory launched a new local anesthetic for clinical use in 14 countries: United Kingdom, Ireland, Germany, Austria, Canada, Italy, France, Belgium, Norway, Switzerland, South Africa, BRAZIL, Argentina, and Portugal.","PeriodicalId":30846,"journal":{"name":"Revista Dor","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Ropivacaine: the newest anesthetic agent celebrates 20 years\",\"authors\":\"J. Nociti\",\"doi\":\"10.5935/1806-0013.20170117\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"On February 22, 1997, the first European Symposium on Ropivacaine was held in Stockholm, Sweden, with the participation of 554 anesthesiologists from 22 countries, including 11 from Brazil. In the same year, Astra Laboratory launched a new local anesthetic for clinical use in 14 countries: United Kingdom, Ireland, Germany, Austria, Canada, Italy, France, Belgium, Norway, Switzerland, South Africa, BRAZIL, Argentina, and Portugal.\",\"PeriodicalId\":30846,\"journal\":{\"name\":\"Revista Dor\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Dor\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5935/1806-0013.20170117\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Dor","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5935/1806-0013.20170117","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 2

摘要

1997年2月22日，第一届罗哌卡因欧洲研讨会在瑞典斯德哥尔摩举行，来自22个国家的554名麻醉师参加了会议，其中包括11名巴西麻醉师。同年，Astra实验室在14个国家推出了一种用于临床的新型局部麻醉剂:英国、爱尔兰、德国、奥地利、加拿大、意大利、法国、比利时、挪威、瑞士、南非、巴西、阿根廷和葡萄牙。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Ropivacaine: the newest anesthetic agent celebrates 20 years

On February 22, 1997, the first European Symposium on Ropivacaine was held in Stockholm, Sweden, with the participation of 554 anesthesiologists from 22 countries, including 11 from Brazil. In the same year, Astra Laboratory launched a new local anesthetic for clinical use in 14 countries: United Kingdom, Ireland, Germany, Austria, Canada, Italy, France, Belgium, Norway, Switzerland, South Africa, BRAZIL, Argentina, and Portugal.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Revista Dor

自引率

0.00%

发文量

审稿时长

15 weeks